Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia.
Nasonova Research Institute of Rheumatology, Moscow, Russia.
Dokl Biochem Biophys. 2024 Aug;517(1):269-276. doi: 10.1134/S1607672924700972. Epub 2024 Jul 13.
Gout is associated with increased risk of cardiovascular disease (CVD) morbidity and mortality. Therefore, an association between coronary heart disease (CHD) and gout deserves careful examination.
. The aim of this study was to determine the prevalence of CHD and factors associated with CHD in patients (pts) with gout.
. The study involved 286 male patients with gout, age 51.2 [42.8; 59.4] years (ys), disease duration 6.2 [3.8; 12.1] ys. All patients underwent standard clinical examination screening traditional risk factors (TRFs) of CVDs. We estimated the adjusted odds ratio (OR) and 95% confidence interval (95% CI).
. CHD was found in 111 out of the 286 pts (38.8%), MI had a history in 29.7%. Compared to individuals with CHD, participants without CHD were older (56.7[52.1; 61.1] vs 46.2[40.6; 53.4] ys), had longer duration of gout (9.3[4.7; 15.1] vs 5.6[3.3; 9.7] ys) (for all p < 0.05). Abdominal obesity (OR, 3.6; 95% CI, 1.2-10.9), family history of CHD (OR, 2.2; 95% CI, 1.3-3.7), disease duration of gout more 10 ys (OR, 2.8; 95% CI, 1.6-4.7), age of gout onset < 35 ys (OR, 5.5; 95% CI, 2.6-11.7), intraosseous tophi (OR, 3.03; 95% CI, 1.8-5.01), nephrolithiasis (OR, 1.7; 95% CI, 1.04-3.04), renal failure (OR, 5.6; 95% CI, 2.7-11.4), serum total cholesterol (TC), (OR, 1.6; 95% CI, 1.0-2.8), serum creatinine (OR, 2.5; 95% CI, 1.2-5.1), increased the risk for CHD in patients with a gout.
. The prevalence of CHD was 38.8% among individuals with gout (one-third of patients had a history of MI 29.7%). Our study showed that both TRFs of CVD and the severity of gout and a history of renal failure contribute to the development of CHD in patients with gout.
本研究旨在确定痛风患者中冠心病(CHD)的患病率和相关因素。
本研究纳入了 286 名年龄 51.2 [42.8;59.4] 岁的男性痛风患者(ys),疾病持续时间为 6.2 [3.8;12.1] ys。所有患者均接受了标准临床检查,筛查心血管疾病(CVDs)的传统危险因素(TRFs)。我们估计了调整后的优势比(OR)和 95%置信区间(95%CI)。
286 例患者中,111 例(38.8%)患有 CHD,29.7%有心肌梗死病史。与无 CHD 的患者相比,有 CHD 的患者年龄更大(56.7[52.1;61.1] vs 46.2[40.6;53.4] ys),痛风持续时间更长(9.3[4.7;15.1] vs 5.6[3.3;9.7] ys)(均<0.05)。腹型肥胖(OR,3.6;95%CI,1.2-10.9)、CHD 家族史(OR,2.2;95%CI,1.3-3.7)、痛风病程>10 ys(OR,2.8;95%CI,1.6-4.7)、痛风发病年龄<35 ys(OR,5.5;95%CI,2.6-11.7)、骨内痛风石(OR,3.03;95%CI,1.8-5.01)、肾结石(OR,1.7;95%CI,1.04-3.04)、肾功能衰竭(OR,5.6;95%CI,2.7-11.4)、血清总胆固醇(TC)(OR,1.6;95%CI,1.0-2.8)、血清肌酐(OR,2.5;95%CI,1.2-5.1),增加了痛风患者发生 CHD 的风险。
痛风患者中 CHD 的患病率为 38.8%(三分之一的患者有心肌梗死病史 29.7%)。本研究表明,心血管疾病的 TRFs 以及痛风的严重程度和肾功能衰竭病史均与痛风患者 CHD 的发生有关。